Risk-Based Screening for the Evaluation of Atrial Fibrillation Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 755 participants.
Also called NCT03911986
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 755 participants
- Registry
-
NCT03911986
-
- Other papers using this trial's data
- Risk-based screening for the evaluation of atrial fibrillation in general practice (R-BEAT): a randomized cross-over trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Ireland
- Registry status
- Completed
Technical summary
Registry record NCT03911986. Randomized; no masking; primary purpose screening. Start 2018-03-21 (actual); primary completion 2023-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Risk-Based Screening for the Evaluation of Atrial Fibrillation Trial
- Acronym
- R-BEAT
- Condition
- Atrial Fibrillation and Flutter
- Intervention (Device)
- R Test 4 External Loop Recorder
- Lead sponsor
- National University of Ireland, Galway, Ireland
- Collaborator
- Health Research Board, Ireland
Record details
- Record id
cardio:ct-nct03911986- Content hash
067fa07d6aedadf99612aa087d9f0455380a9d8d1e49fe78bb74c06a5a353a85